Both in R&D — Physical & Biological Sciences
Medpace Holdings vs MaxCyte
Over the past year MEDP returned +10.5% and MXCT returned −13.7%; their daily moves had a correlation of 0.17.
MEDP +10.5% MXCT −13.7%Growth of $1, one year, split-adjusted
| Metric | MEDP | MXCT |
|---|---|---|
| Price | $656.77 | $1.39 |
| Market cap | $18.37B | $143.5M |
| Today | −1.01% | −4.79% |
| 1 month | +8.9% | +27.5% |
| 6 months | +53.9% | +64.2% |
| Year to date | +16.9% | −10.3% |
| 1 year | +10.6% | −13.7% |
| Revenue growth (YoY) | +8.5% | −14.5% |
| Gross margin | 31.3% | 77.0% |
| Net margin | 19.2% | −122.0% |
| P/E (TTM) | 35.5× | — |
| Price / sales | 6.5× | 4.6× |
| Net cash | $705.3M | $105.7M |
| Dividend yield | — | — |
| Volatility (60d) | 29.7% | 82.3% |
| Short % of float | 7.2% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).